Skip to main content
. 2020 Oct 26;23(5):498–508. doi: 10.4048/jbc.2020.23.e58

Table 3. Incidence of late recurrence by site, categorized by patient serum 25(OH)D status after 5-year adjuvant endocrine therapy.

Site of late recurrence Serum 25(OH)D status after 5-yr adjuvant endocrine therapy
Deficient Sufficient Total
Local 2 1 3
Regional LN 23 1 24
Bone 25 7 32
Visceral 26 7 33
Total 76 16 92

25(OH)D = 25-hydroxyvitamin D; LN = lymph node.